Twitter Linkedin Youtube Campus Rubió
Modified-release methylphenidate

Rubifen Prolong® hard capsules of modified release EFG

Home / Products / Rubifen Prolong® hard capsules of modified release EFG. Methylphenidate hydrochloride
THERAPEUTIC INDICATION PRESENTATIONS

THERAPEUTIC INDICATION

Rubifen Prolong® is a modified-release methylphenidate containing 50% MTF immediate release and 50% MTF extended release. It is indicated for the treatment of ADHD in children aged 6 years and older, adolescents and adults.

Access technical file RUBIFEN PROLONG® HARD CAPSULES OF MODIFIED RELEASE EFG

PRESENTATIONS

Rubifen Prolong® hard capsules of modified release EFG

  1. Rubifen Prolong® 20 mg cápsulas duras de liberación modificada EFG, 30 cápsulas
    • Código Nacional: CN 762737
    • PVP IVA: 11,94 €
    • Con receta médica
    • Financiado por la Seguridad Social
    • Aportación normal
  2. Rubifen Prolong® 30 mg cápsulas duras de liberación modificada EFG, 30 cápsulas
    • Código Nacional: CN 762738
    • PVP IVA: 17,91 €
    • Con receta médica
    • Financiado por la Seguridad Social
    • Aportación normal
  3. Rubifen Prolong® 40 mg cápsulas duras de liberación modificada EFG, 30 cápsulas
    • Código Nacional: CN 762739
    • PVP IVA: 23,88 €
    • Con receta médica
    • Financiado por la Seguridad Social
    • Aportación normal
  4. Rubifen Prolong® 60 mg cápsulas duras de liberación modificada EFG, 30 cápsulas
    • Código Nacional: CN 762742
    • PVP IVA: 35,83 €
    • Con receta médica
    • Financiado por la Seguridad Social
    • Aportación normal

Presentations: 10, 20, 30, 40, and 60 mg in a 30-tablet format in boxes with child-proof safety blister packs.

Administration: orally once a day in the morning, with or without food. Swallow the capsule whole. It can also be opened and the contents poured into soft food (such as applesauce) and administered immediately. The mixture must be taken immediately and should not be heated, chewed, or crushed.

The recommended initial dose is 20 mg.

The maximum daily dose in children is 60 mg and 80 mg in adults.

Scroll up

The information contained in this area is directed exclusively to healthcare professionals with the capacity to prescribe or dispense medications.

I am healthcare personnel
I am not healthcare personnel
Our site uses cookies to collect information about your device and browsing activity. We use this data to improve the site, ensure security and deliver personalized content. You can manage your cookie preferences by clicking here.
Accept cookies Configure Decline cookies
Basic cookie information
This website uses cookies and/or similar technologies that store and retrieve information when you browse. In general, these technologies can serve very different purposes, such as, for example, recognizing you as a user, obtaining information about your browsing habits or personalizing the way in which the content is displayed. The specific uses we make of these technologies are described below. By default, all cookies are disabled, except for technical ones, which are necessary for the website to function. If you wish to obtain more information or exercise your data protection rights, you can consult our "Política de cookies".
Accept cookies Configure
Technical cookies needed Always active
Technical cookies are strictly necessary for our website to work and for you to navigate through it. These types of cookies are those that, for example, allow us to identify you, give you access to certain restricted parts of the page if necessary, or remember different options or services already selected by you, such as your privacy preferences. Therefore, they are activated by default, your authorization is not necessary. Through the configuration of your browser, you can block or alert the presence of this type of cookies, although such blocking will affect the proper functioning of the different functionalities of our website.
Analysis cookies
Analysis cookies are those used to carry out anonymous analysis of the behavior of web users and allow measuring user activity and creating navigation profiles in order to improve the websites.
Confirm preferences
We want everyone to have access to our medicines wherever they are, regardless of prevalence.
OUR PRODUCTS